ZA200404737B - Nano-composite martensitic steels - Google Patents
Nano-composite martensitic steels Download PDFInfo
- Publication number
- ZA200404737B ZA200404737B ZA200404737A ZA200404737A ZA200404737B ZA 200404737 B ZA200404737 B ZA 200404737B ZA 200404737 A ZA200404737 A ZA 200404737A ZA 200404737 A ZA200404737 A ZA 200404737A ZA 200404737 B ZA200404737 B ZA 200404737B
- Authority
- ZA
- South Africa
- Prior art keywords
- promoter
- vector
- expression
- heterologous protein
- gene
- Prior art date
Links
- 229910000831 Steel Inorganic materials 0.000 title 1
- 229910000734 martensite Inorganic materials 0.000 title 1
- 239000002114 nanocomposite Substances 0.000 title 1
- 239000010959 steel Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims description 101
- 102000004169 proteins and genes Human genes 0.000 claims description 65
- 230000014509 gene expression Effects 0.000 claims description 44
- 239000013598 vector Substances 0.000 claims description 36
- 101100103043 Escherichia coli (strain K12) xapA gene Proteins 0.000 claims description 29
- UBORTCNDUKBEOP-UUOKFMHZSA-N xanthosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UUOKFMHZSA-N 0.000 claims description 27
- 210000004027 cell Anatomy 0.000 claims description 25
- UBORTCNDUKBEOP-UHFFFAOYSA-N L-xanthosine Natural products OC1C(O)C(CO)OC1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UHFFFAOYSA-N 0.000 claims description 24
- UBORTCNDUKBEOP-HAVMAKPUSA-N Xanthosine Natural products O[C@@H]1[C@H](O)[C@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-HAVMAKPUSA-N 0.000 claims description 24
- 239000002773 nucleotide Substances 0.000 claims description 23
- 125000003729 nucleotide group Chemical group 0.000 claims description 23
- 150000007523 nucleic acids Chemical group 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- 101100103045 Escherichia coli (strain K12) xapR gene Proteins 0.000 claims description 19
- 239000013604 expression vector Substances 0.000 claims description 18
- 230000001105 regulatory effect Effects 0.000 claims description 17
- 230000027455 binding Effects 0.000 claims description 12
- 101150106831 xapR gene Proteins 0.000 claims description 12
- 239000013612 plasmid Substances 0.000 claims description 11
- 230000001939 inductive effect Effects 0.000 claims description 10
- 102000039446 nucleic acids Human genes 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 10
- 210000003705 ribosome Anatomy 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 7
- 102000004127 Cytokines Human genes 0.000 claims description 4
- 108090000695 Cytokines Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 239000005556 hormone Substances 0.000 claims description 4
- 229940088597 hormone Drugs 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 101150090059 xapA gene Proteins 0.000 claims description 4
- 102000019034 Chemokines Human genes 0.000 claims description 3
- 108010012236 Chemokines Proteins 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 241001515965 unidentified phage Species 0.000 claims description 2
- 101710204837 Envelope small membrane protein Proteins 0.000 claims 1
- 101710088839 Replication initiation protein Proteins 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 description 25
- 230000006698 induction Effects 0.000 description 20
- 108010000521 Human Growth Hormone Proteins 0.000 description 12
- 239000012634 fragment Substances 0.000 description 12
- 102000002265 Human Growth Hormone Human genes 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 9
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 9
- 239000000854 Human Growth Hormone Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 238000004925 denaturation Methods 0.000 description 8
- 230000036425 denaturation Effects 0.000 description 8
- 238000000137 annealing Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000002777 nucleoside Substances 0.000 description 7
- 229920001184 polypeptide Chemical group 0.000 description 7
- 108090000765 processed proteins & peptides Chemical group 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 108090000978 Interleukin-4 Proteins 0.000 description 6
- 238000001262 western blot Methods 0.000 description 6
- 102000004388 Interleukin-4 Human genes 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 101100467813 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RBS1 gene Proteins 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 125000003835 nucleoside group Chemical group 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 108091081024 Start codon Proteins 0.000 description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011210 chromatographic step Methods 0.000 description 4
- 210000003000 inclusion body Anatomy 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 108091035707 Consensus sequence Proteins 0.000 description 3
- 101100103044 Escherichia coli (strain K12) xapB gene Proteins 0.000 description 3
- 101001002709 Homo sapiens Interleukin-4 Proteins 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 102000055229 human IL4 Human genes 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 239000000411 inducer Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 210000001322 periplasm Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 108010054278 Lac Repressors Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- PGAVKCOVUIYSFO-UHFFFAOYSA-N [[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 238000000326 densiometry Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 108091006104 gene-regulatory proteins Proteins 0.000 description 2
- 102000034356 gene-regulatory proteins Human genes 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229940029575 guanosine Drugs 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940104230 thymidine Drugs 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- LFRDGHVRPSURMV-YFKPBYRVSA-N (4s)-4,5-dihydroxypentanal Chemical compound OC[C@@H](O)CCC=O LFRDGHVRPSURMV-YFKPBYRVSA-N 0.000 description 1
- 108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 description 1
- 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101100136076 Aspergillus oryzae (strain ATCC 42149 / RIB 40) pel1 gene Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 101100499233 Caenorhabditis elegans dhs-5 gene Proteins 0.000 description 1
- 101100069857 Caenorhabditis elegans hil-4 gene Proteins 0.000 description 1
- 101000709520 Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) Atypical response regulator protein ChxR Proteins 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 102000003939 Membrane transport proteins Human genes 0.000 description 1
- 108090000301 Membrane transport proteins Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 101710197208 Regulatory protein cro Proteins 0.000 description 1
- 102000009661 Repressor Proteins Human genes 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 101100446206 Schizosaccharomyces pombe (strain 972 / ATCC 24843) xap5 gene Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 description 1
- 108010045605 Xanthosine phosphorylase Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 101150042295 arfA gene Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940028885 interleukin-4 Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 101150087557 omcB gene Proteins 0.000 description 1
- 101150115693 ompA gene Proteins 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 101150040383 pel2 gene Proteins 0.000 description 1
- 101150050446 pelB gene Proteins 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- -1 phosphate ester Chemical class 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 229950010342 uridine triphosphate Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C38/00—Ferrous alloys, e.g. steel alloys
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C38/00—Ferrous alloys, e.g. steel alloys
- C22C38/18—Ferrous alloys, e.g. steel alloys containing chromium
- C22C38/40—Ferrous alloys, e.g. steel alloys containing chromium with nickel
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C38/00—Ferrous alloys, e.g. steel alloys
- C22C38/18—Ferrous alloys, e.g. steel alloys containing chromium
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C38/00—Ferrous alloys, e.g. steel alloys
- C22C38/18—Ferrous alloys, e.g. steel alloys containing chromium
- C22C38/40—Ferrous alloys, e.g. steel alloys containing chromium with nickel
- C22C38/58—Ferrous alloys, e.g. steel alloys containing chromium with nickel with more than 1.5% by weight of manganese
-
- C—CHEMISTRY; METALLURGY
- C21—METALLURGY OF IRON
- C21D—MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS; GENERAL DEVICES FOR HEAT TREATMENT OF FERROUS OR NON-FERROUS METALS OR ALLOYS; MAKING METAL MALLEABLE, e.g. BY DECARBURISATION OR TEMPERING
- C21D2201/00—Treatment for obtaining particular effects
- C21D2201/03—Amorphous or microcrystalline structure
-
- C—CHEMISTRY; METALLURGY
- C21—METALLURGY OF IRON
- C21D—MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS; GENERAL DEVICES FOR HEAT TREATMENT OF FERROUS OR NON-FERROUS METALS OR ALLOYS; MAKING METAL MALLEABLE, e.g. BY DECARBURISATION OR TEMPERING
- C21D2211/00—Microstructure comprising significant phases
- C21D2211/001—Austenite
-
- C—CHEMISTRY; METALLURGY
- C21—METALLURGY OF IRON
- C21D—MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS; GENERAL DEVICES FOR HEAT TREATMENT OF FERROUS OR NON-FERROUS METALS OR ALLOYS; MAKING METAL MALLEABLE, e.g. BY DECARBURISATION OR TEMPERING
- C21D2211/00—Microstructure comprising significant phases
- C21D2211/008—Martensite
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Heat Treatment Of Steel (AREA)
- Heat Treatment Of Sheet Steel (AREA)
- Heat Treatment Of Strip Materials And Filament Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/017,879 US6709534B2 (en) | 2001-12-14 | 2001-12-14 | Nano-composite martensitic steels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200404737B true ZA200404737B (en) | 2006-12-27 |
Family
ID=21785041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200404737A ZA200404737B (en) | 2001-12-14 | 2002-12-12 | Nano-composite martensitic steels |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6709534B2 (enExample) |
| EP (1) | EP1461466B1 (enExample) |
| JP (2) | JP4776167B2 (enExample) |
| KR (2) | KR20040081434A (enExample) |
| CN (1) | CN1325685C (enExample) |
| AR (1) | AR037830A1 (enExample) |
| AT (1) | ATE402272T1 (enExample) |
| AU (1) | AU2002357853B2 (enExample) |
| BR (1) | BR0214964A (enExample) |
| CA (1) | CA2470384C (enExample) |
| DE (1) | DE60227839D1 (enExample) |
| ES (1) | ES2309219T3 (enExample) |
| MX (1) | MXPA04005744A (enExample) |
| NO (1) | NO340616B1 (enExample) |
| NZ (1) | NZ533659A (enExample) |
| PT (1) | PT1461466E (enExample) |
| RU (1) | RU2293768C2 (enExample) |
| UA (1) | UA75501C2 (enExample) |
| WO (1) | WO2003052152A1 (enExample) |
| ZA (1) | ZA200404737B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040149362A1 (en) * | 2002-11-19 | 2004-08-05 | Mmfx Technologies Corporation, A Corporation Of The State Of California | Cold-worked steels with packet-lath martensite/austenite microstructure |
| US20060065327A1 (en) * | 2003-02-07 | 2006-03-30 | Advance Steel Technology | Fine-grained martensitic stainless steel and method thereof |
| US6890393B2 (en) * | 2003-02-07 | 2005-05-10 | Advanced Steel Technology, Llc | Fine-grained martensitic stainless steel and method thereof |
| US6899773B2 (en) * | 2003-02-07 | 2005-05-31 | Advanced Steel Technology, Llc | Fine-grained martensitic stainless steel and method thereof |
| US20070228729A1 (en) * | 2003-03-06 | 2007-10-04 | Grimmett Harold M | Tubular goods with threaded integral joint connections |
| US20060006648A1 (en) * | 2003-03-06 | 2006-01-12 | Grimmett Harold M | Tubular goods with threaded integral joint connections |
| US7169239B2 (en) | 2003-05-16 | 2007-01-30 | Lone Star Steel Company, L.P. | Solid expandable tubular members formed from very low carbon steel and method |
| US7214278B2 (en) * | 2004-12-29 | 2007-05-08 | Mmfx Technologies Corporation | High-strength four-phase steel alloys |
| CN1328406C (zh) * | 2005-06-22 | 2007-07-25 | 宁波浙东精密铸造有限公司 | 一种薄膜奥氏体增韧的马氏体耐磨铸钢及其制造方法 |
| CN100357460C (zh) * | 2006-03-14 | 2007-12-26 | 钢铁研究总院 | 一种获得多元组织马氏体钢的冷却工艺 |
| EP2044228B1 (en) * | 2006-06-29 | 2010-05-19 | Tenaris Connections AG | Seamless precision steel tubes with improved isotropic toughness at low temperature for hydraulic cylinders and process for obtaining the same |
| RU2360029C1 (ru) * | 2008-01-09 | 2009-06-27 | Открытое акционерное общество "Научно-исследовательский институт металлургической технологии" | Высокопрочная немагнитная композиционная сталь |
| EP2325435B2 (en) | 2009-11-24 | 2020-09-30 | Tenaris Connections B.V. | Threaded joint sealed to [ultra high] internal and external pressures |
| US20110236696A1 (en) * | 2010-03-25 | 2011-09-29 | Winky Lai | High strength rebar |
| US9163296B2 (en) | 2011-01-25 | 2015-10-20 | Tenaris Coiled Tubes, Llc | Coiled tube with varying mechanical properties for superior performance and methods to produce the same by a continuous heat treatment |
| IT1403688B1 (it) | 2011-02-07 | 2013-10-31 | Dalmine Spa | Tubi in acciaio con pareti spesse con eccellente durezza a bassa temperatura e resistenza alla corrosione sotto tensione da solfuri. |
| IT1403689B1 (it) | 2011-02-07 | 2013-10-31 | Dalmine Spa | Tubi in acciaio ad alta resistenza con eccellente durezza a bassa temperatura e resistenza alla corrosione sotto tensioni da solfuri. |
| US8414715B2 (en) | 2011-02-18 | 2013-04-09 | Siderca S.A.I.C. | Method of making ultra high strength steel having good toughness |
| US8636856B2 (en) | 2011-02-18 | 2014-01-28 | Siderca S.A.I.C. | High strength steel having good toughness |
| FI20115702L (fi) * | 2011-07-01 | 2013-01-02 | Rautaruukki Oyj | Menetelmä suurlujuuksisen rakenneteräksen valmistamiseksi ja suurlujuuksinen rakenneteräs |
| JP5910168B2 (ja) * | 2011-09-15 | 2016-04-27 | 臼井国際産業株式会社 | Ｔｒｉｐ型２相マルテンサイト鋼及びその製造方法とそのｔｒｉｐ型２相マルテンサイト鋼を用いた超高強度鋼製加工品 |
| US9340847B2 (en) | 2012-04-10 | 2016-05-17 | Tenaris Connections Limited | Methods of manufacturing steel tubes for drilling rods with improved mechanical properties, and rods made by the same |
| RU2495141C1 (ru) * | 2012-05-11 | 2013-10-10 | Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Донской Государственный Технический Университет" (Дгту) | Способ получения естественного феррито-мартенситного композита |
| CN102703837B (zh) * | 2012-05-25 | 2014-05-14 | 燕山大学 | 一种纳米结构板条马氏体钢及其制备方法 |
| GB2525337B (en) | 2013-01-11 | 2016-06-22 | Tenaris Connections Ltd | Galling resistant drill pipe tool joint and corresponding drill pipe |
| US9187811B2 (en) | 2013-03-11 | 2015-11-17 | Tenaris Connections Limited | Low-carbon chromium steel having reduced vanadium and high corrosion resistance, and methods of manufacturing |
| US8978430B2 (en) | 2013-03-13 | 2015-03-17 | Commercial Metals Company | System and method for stainless steel cladding of carbon steel pieces |
| US9803256B2 (en) | 2013-03-14 | 2017-10-31 | Tenaris Coiled Tubes, Llc | High performance material for coiled tubing applications and the method of producing the same |
| EP2789701A1 (en) | 2013-04-08 | 2014-10-15 | DALMINE S.p.A. | High strength medium wall quenched and tempered seamless steel pipes and related method for manufacturing said steel pipes |
| EP2789700A1 (en) | 2013-04-08 | 2014-10-15 | DALMINE S.p.A. | Heavy wall quenched and tempered seamless steel pipes and related method for manufacturing said steel pipes |
| JP6144417B2 (ja) | 2013-06-25 | 2017-06-07 | テナリス・コネクシヨンズ・ベー・ブイ | 高クロム耐熱鋼 |
| US20160305192A1 (en) | 2015-04-14 | 2016-10-20 | Tenaris Connections Limited | Ultra-fine grained steels having corrosion-fatigue resistance |
| US11124852B2 (en) | 2016-08-12 | 2021-09-21 | Tenaris Coiled Tubes, Llc | Method and system for manufacturing coiled tubing |
| CN106282495B (zh) * | 2016-10-27 | 2018-03-27 | 贵州大学 | 中高碳铬钒钢中形成微纳尺度孪晶马氏体的工艺方法 |
| KR101899670B1 (ko) | 2016-12-13 | 2018-09-17 | 주식회사 포스코 | 저온역 버링성이 우수한 고강도 복합조직강 및 그 제조방법 |
| US10434554B2 (en) | 2017-01-17 | 2019-10-08 | Forum Us, Inc. | Method of manufacturing a coiled tubing string |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4170499A (en) | 1977-08-24 | 1979-10-09 | The Regents Of The University Of California | Method of making high strength, tough alloy steel |
| US4170497A (en) | 1977-08-24 | 1979-10-09 | The Regents Of The University Of California | High strength, tough alloy steel |
| US4619714A (en) | 1984-08-06 | 1986-10-28 | The Regents Of The University Of California | Controlled rolling process for dual phase steels and application to rod, wire, sheet and other shapes |
| US4671827A (en) | 1985-10-11 | 1987-06-09 | Advanced Materials And Design Corp. | Method of forming high-strength, tough, corrosion-resistant steel |
| US5180450A (en) * | 1990-06-05 | 1993-01-19 | Ferrous Wheel Group Inc. | High performance high strength low alloy wrought steel |
| SU1749307A1 (ru) * | 1990-10-30 | 1992-07-23 | Центральный научно-исследовательский институт черной металлургии им.И.П.Бардина | Сталь |
| US5545269A (en) * | 1994-12-06 | 1996-08-13 | Exxon Research And Engineering Company | Method for producing ultra high strength, secondary hardening steels with superior toughness and weldability |
| US5545270A (en) * | 1994-12-06 | 1996-08-13 | Exxon Research And Engineering Company | Method of producing high strength dual phase steel plate with superior toughness and weldability |
| US6264760B1 (en) * | 1997-07-28 | 2001-07-24 | Exxonmobil Upstream Research Company | Ultra-high strength, weldable steels with excellent ultra-low temperature toughness |
| US6159312A (en) * | 1997-12-19 | 2000-12-12 | Exxonmobil Upstream Research Company | Ultra-high strength triple phase steels with excellent cryogenic temperature toughness |
| UA73311C2 (uk) * | 1999-07-12 | 2005-07-15 | Ммфекс Стил Корпорейшн Оф Америка | Низьковуглецеві сталі з високими механічними і корозійними властивостями та спосіб їх виготовлення |
| CN1079447C (zh) * | 1999-11-30 | 2002-02-20 | 河北工业大学 | 无界面碳化物低碳马氏体高强度钢 |
| CN1120247C (zh) * | 2000-02-02 | 2003-09-03 | 燕山大学 | 纳米晶粒低合金钢板的制造方法 |
| JP2001234286A (ja) * | 2000-02-24 | 2001-08-28 | Nippon Steel Corp | 伸線加工性に優れた細径高炭素低合金鋼熱間圧延線材とその製造方法 |
| CN1107728C (zh) * | 2000-04-25 | 2003-05-07 | 钢铁研究总院 | 一种合金结构钢的晶粒超细化方法 |
-
2001
- 2001-12-14 US US10/017,879 patent/US6709534B2/en not_active Expired - Lifetime
-
2002
- 2002-12-12 KR KR10-2004-7009227A patent/KR20040081434A/ko not_active Ceased
- 2002-12-12 ES ES02792396T patent/ES2309219T3/es not_active Expired - Lifetime
- 2002-12-12 PT PT02792396T patent/PT1461466E/pt unknown
- 2002-12-12 KR KR1020087031418A patent/KR20090007500A/ko not_active Ceased
- 2002-12-12 AT AT02792396T patent/ATE402272T1/de not_active IP Right Cessation
- 2002-12-12 ZA ZA200404737A patent/ZA200404737B/en unknown
- 2002-12-12 JP JP2003553019A patent/JP4776167B2/ja not_active Expired - Fee Related
- 2002-12-12 AU AU2002357853A patent/AU2002357853B2/en not_active Ceased
- 2002-12-12 CN CNB028279654A patent/CN1325685C/zh not_active Expired - Fee Related
- 2002-12-12 DE DE60227839T patent/DE60227839D1/de not_active Expired - Lifetime
- 2002-12-12 CA CA2470384A patent/CA2470384C/en not_active Expired - Lifetime
- 2002-12-12 EP EP02792396A patent/EP1461466B1/en not_active Expired - Lifetime
- 2002-12-12 MX MXPA04005744A patent/MXPA04005744A/es active IP Right Grant
- 2002-12-12 RU RU2004121459/02A patent/RU2293768C2/ru not_active IP Right Cessation
- 2002-12-12 BR BRPI0214964-8A patent/BR0214964A/pt not_active Application Discontinuation
- 2002-12-12 UA UA20040705662A patent/UA75501C2/uk unknown
- 2002-12-12 NZ NZ533659A patent/NZ533659A/en not_active IP Right Cessation
- 2002-12-12 WO PCT/US2002/040063 patent/WO2003052152A1/en not_active Ceased
- 2002-12-13 AR ARP020104849A patent/AR037830A1/es not_active Application Discontinuation
-
2003
- 2003-04-02 US US10/406,780 patent/US7118637B2/en not_active Expired - Lifetime
-
2004
- 2004-07-13 NO NO20042996A patent/NO340616B1/no not_active IP Right Cessation
-
2009
- 2009-01-13 JP JP2009005219A patent/JP2009120958A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200404737B (en) | Nano-composite martensitic steels | |
| US4914027A (en) | Process for the microbiological preparation of human serum albumin | |
| US5710027A (en) | Process and vector for expressing alpha-interferon in E. coli | |
| US4582800A (en) | Novel vectors and method for controlling interferon expression | |
| Bartowsky et al. | Purification and mutant analysis of Citrobacter freundii AmpR, the regulator for chromosomal AmpC β‐lactamase | |
| Seeger et al. | Identification and characterization of genes (xapA, xapB, and xapR) involved in xanthosine catabolism in Escherichia coli | |
| JP7026906B2 (ja) | 転写調節融合ポリペプチド | |
| US4992367A (en) | Enhanced expression of human interleukin-2 in mammalian cells | |
| Tsurimoto et al. | Bacteriophage lambda initiators: preparation from a strain that overproduces the O and P proteins | |
| Malekian et al. | High-yield production of granulocyte-macrophage colony-stimulating factor in E. coli BL21 (DE3) by an auto-induction strategy | |
| US20120196323A1 (en) | Fermentation Process | |
| EP1461437B1 (en) | Expression vectors and promoters for heterologous gene expression | |
| Ivanov et al. | Unusual effect of clusters of rare arginine (AGG) codons on the expression of human interferon α1 gene in Escherichia coli | |
| Roberts et al. | [24] The use of synthetic oligodeoxyribonucleotides in the examination of calmodulin gene and protein structure and function | |
| US5654169A (en) | Vectors and transformed host cells for recombinant protein production at reduced temperatures | |
| Vysotskaya et al. | The ribosomal protein S8 from Thermus thermophilus VK1: Sequencing of the gene, overexpression of the protein in Escherichia coli and interaction with rRNA | |
| JPH06311884A (ja) | プラスミド及びそれで形質転換されたエ シェリチア・コリ | |
| JPH0335795A (ja) | ヒトインターロイキン２活性をもつポリペプチドの製造法 | |
| US7235385B2 (en) | Methods for enhancing expression of recombinant proteins | |
| CA1197481A (en) | Recombinant dna | |
| SK762000A3 (en) | Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins | |
| Cox et al. | Altered translation of the uncC gene coding for the epsilon subunit of the F1F0-ATPase of Escherichia coli | |
| JPH0928380A (ja) | ニトリラーゼ遺伝子発現に関わる調節因子およびその遺伝子 | |
| EP1656452A2 (en) | Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides | |
| JP2664802B2 (ja) | イオンチャンネル直結型受容体ｎ末端細胞外部位蛋白質の生産方法 |